Four-week histologic evaluation of grafted calvarial defects with adjunctive hyperbaric oxygen therapy in rats

다국어 초록 (Multilingual Abstract)

Purpose: The aim of this study was to characterize the healing in the grafted calvarial defects of rats after adjunctive hyperbaric oxygen therapy.
Methods: Twenty-eight male Sprague-Dawley rats (body weight, 250–300 g) were randomly divided into two treatment groups: with hyperbaric oxygen therapy (HBO; n=14) and without HBO (NHBO; n=14). Each group was further subdivided according to the bone substitute applied: biphasic calcium phosphate (BCP; n=7) and surface-modified BCP (mBCP; n=7). The mBCP comprised BCP coated with Escherichia-coli-derived recombinant human bone morphogenetic protein-2 (ErhBMP-2) and epigallocatechin-3-gallate (EGCG). Two symmetrical circular defects (6-mm diameter) were created in the right and left parietal bones of each animal. One defect was assigned as a control defect and received no bone substitute, while the other defect was filled with either BCP or mBCP. The animals were allowed to heal for 4 weeks, during which those in the HBO group underwent 5 sessions of HBO. At 4 weeks, the animals were sacrificed, and the defects were harvested for histologic and histomorphometric analysis.
Results: Well-maintained space was found in the grafted groups. Woven bone connected to and away from the defect margin was formed. More angiogenesis was found with HBO and EGCG/BMP-2 (P<0.05). None of the defects achieved complete defect closure. Increased new bone formation with HBO or EGCG/BMP-2 was evident in histologic evaluation, but it did not reach statistical significance in histometric analysis. A synergic effect between HBO and EGCG/BMP-2 was not found.
Conclusions: Within the limitations of this study, the present findings indicate that adjunctive HBO and EGCG/BMP-2 could be beneficial for new bone formation in rat calvarial defects.

참고문헌 (Reference)

1 Sirin Y, "The influence of hyperbaric oxygen treatment on the healing of experimental defects filled with different bone graft substitutes" 8 : 114-125, 2011

2 Shin YS, "The effects of ErhBMP-2-/EGCG-coated BCP bone substitute on dehiscence around dental implants in dogs" 20 : 281-287, 2014

3 Oka Y, "Tea polyphenols inhibit rat osteoclast formation and differentiation" 118 : 55-64, 2012

4 Lysdahl H, "Preconditioning human mesenchymal stem cells with a low concentration of BMP2 stimulates proliferation and osteogenic differentiation in vitro" 3 : 278-285, 2014

5 Howard MA, "Oxygen and wound care: a review of current therapeutic modalities and future direction" 21 : 503-511, 2013

6 Muhonen A, "Osteodistraction of a previously irradiated mandible with or without adjunctive hyperbaric oxygenation: an experimental study in rabbits" 31 : 519-524, 2002

7 Muhonen A, "Osteoblastic activity and neoangiogenesis in distracted bone of irradiated rabbit mandible with or without hyperbaric oxygen treatment" 33 : 173-178, 2004

8 Kim MS, "Low-dose recombinant human bone morphogenetic protein-2 to enhance the osteogenic potential of the Schneiderian membrane in the early healing phase: in vitro and in vivo studies" 72 : 1480-1494, 2014

9 최현민, "Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with two concentrations of expressed recombinant human bone morphogenetic protein 2" 대한치주과학회 42 (42): 119-126, 2012

10 최현민, "Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with synthetic cell binding peptide sequences" 대한치주과학회 42 (42): 166-172, 2012

11 Hopf HW, "Hyperoxia and angiogenesis" 13 : 558-564, 2005

12 Milovanova TN, "Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo" 106 : 711-728, 2009

13 Fok TC, "Hyperbaric oxygen results in increased vascular endothelial growth factor (VEGF) protein expression in rabbit calvarial critical-sized defects" 105 : 417-422, 2008

14 Jan AM, "Hyperbaric oxygen results in an increase in rabbit calvarial critical sized defects" 101 : 144-149, 2006

15 Park JS, "Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2" 29 : 1247-1252, 2006

16 Jin P, "Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study" 356 : 381-390, 2014

17 Kaigler D, "Endothelial cell modulation of bone marrow stromal cell osteogenic potential" 19 : 665-667, 2005

18 Bai Y, "Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo" 356 : 109-121, 2014

19 Jan A, "Effect of hyperbaric oxygen on grafted and nongrafted calvarial critical-sized defects" 107 : 157-163, 2009

20 Cai WX, "Effect of different rhBMP-2 and TG-VEGF ratios on the formation of heterotopic bone and neovessels" 2014 : 571510-, 2014

21 Laurencin C, "Bone graft substitutes" 3 : 49-57, 2006

22 Wang DS, "Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells" 138 : 2953-2962, 1997

23 Palti A, "A concept for the treatment of various dental bone defects" 11 : 73-78, 2002